Money money money... [startup company venture capital fund raising]

2005 ◽  
Vol 15 (4) ◽  
pp. 34-37
Author(s):  
B. Parmar
Author(s):  
Wendell E. Dunn ◽  
Scott Shane

This case describes the evolution of an entrepreneur's venture-capital fund-raising from seed-stage financing through later-round efforts. The case focuses on where the “action” is in venture finance: the exploitation of social capital by an entrepreneur and investors. Much of the teaching materials on venture finance focus on the economics of financing; while these materials provide useful information about the mechanics of valuation and how to structure venture-capital agreements, they miss the social side of venture-capital investing. The case illustrates the theoretical concept that social capital (i.e., a person's relationship to other people in society) influences venture finance. The case can be used in a class on entrepreneurship or venture finance.


2012 ◽  
Vol 7 (1-2) ◽  
pp. 24-29
Author(s):  
Judit Glavanits

Closing the gap between the USA and EU venture capital market size is crutial for european innovative small and medium sized companies. As the financial crises started in 2008 weekend the possibilities for external capital, the role of venture capital financing is revaluated. The study analyses the similarities and differences in the legal rules of venture capital fund raising and financing revised by the USA's Dodd-Frank Act, and the European AIMF-directive. The study also suggest the changes in connection with the European Commission's prepared document on the European Venture Capital Fund, and it's effects on the innovative small-and medium sized companies. The conclusion is that the new rules of venture financing both in the USA and Europe sets up significantly more administrative difficulties for funds, but more stability and safe for entrepreneurs.


CFA Digest ◽  
2012 ◽  
Vol 42 (1) ◽  
pp. 19-21
Author(s):  
Brindha Gunasingham

1992 ◽  
Vol 6 (3) ◽  
pp. 143-146
Author(s):  
John E. Bagalay

Boston University has a successful record of investing in high-technology companies. These investments are carried out through the university's wholly owned venture capital fund. One of Boston University's most important investments has been in Seragen, Inc, a biotechnology company. Seragen's activities and its recent public offering of shares are described. Finally, the article sets Boston University's entrepreneurial activities in the context of the debate about the morality of universities commercializing their research.


2009 ◽  
Vol 11 (1) ◽  
pp. 23-54 ◽  
Author(s):  
Douglas Cumming ◽  
Sofia Johan

2009 ◽  
Vol 62 (9) ◽  
pp. 906-912 ◽  
Author(s):  
Luis J. Sanz ◽  
Mario Lazzaroni

Sign in / Sign up

Export Citation Format

Share Document